It’s been a minute since the market has seen a medical cannabis company go public via a SPAC. Phytanix Bio, a pharmaceutical company dedicated to the development of therapeutics based on cannabinoid and cannabinoid-like molecules is going public through a Special Purpose Acquisition Corp. called Chain Bridge I (Nasdaq: CBRG). …